Venture capital firm 83North is leading the €30 million funding round. New investor La Famiglia supports Orbem, as do existing investors The Venture Collective, Possible Ventures and Dr. Rüdiger Schmidt. The investor group also includes several prominent German entrepreneurs, including Personio co-founders Hanno Renner, Roman Schumacher and Chief Operating Officer Jonas Rieke, former Zalando CEO Rubin Ritter, Forto co-founders Michael Wax, Erik Muttersbach and Chief Operating Officer Dr. Michael Ardelt, Kinexon co-founders Dr. Alexander Hüttenbrink and Dr. Oliver Trinchera, and Bastian Nominacher, co-CEO and co-founder of Celonis.
Using AI-powered MRT technology, the deeptech can scan various biological samples such as food, plant species, building materials and the human body. The AI essentially takes over the tasks of technicians and radiologists. This makes MRT procedures significantly faster and interesting for a range of previously untapped markets.
The Series A round follows the market launch of Orbem Genus Focus, a product that determines the sex of a chicken egg in a completely non-invasive way. This eliminates the controversial practice of culling male chicks. According to the company’s own data, the startup has already convinced leading poultry producers, achieved profitability and scanned more than 21 million eggs.
“Solving the world’s greatest challenges with AI-powered imaging”
“Our mission is to enable AI-powered imaging for everything and everyone. We believe this is the best way to achieve our main goal of bringing light to the world’s greatest challenges. With €30 million in funding, we have maximum flexibility to realize our vision of using AI-powered imaging to sustainably improve global food security, accelerate the transition to a green economy, and transform disease detection”,
says Pedro Gómez, co-founder and CEO of Orbem. Gil Goren, General Partner at 83North, comments on the investment as follows:
“The era of digitalization, groundbreaking technological innovation and the AI revolution offers companies a unique opportunity to solve real challenges and build solid, independent businesses. Orbem has leveraged AI to industrialize MRT technology and unlock the potential to revolutionize food production, accelerate the transition to a sustainable economy, and improve disease detection. It is a great pleasure for me to accompany this amazing team on their journey to a better world.”
